This Article Full Text (PDF) All Versions of this Article: 0003319706292015v1 58/4/429    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Saito, S. Articles by Goto, F. Search for Related Content PubMed PubMed Citation Articles by Saito, S. Articles by Goto, F. Pubmed/NCBI databases Medline Plus Health Information Bone Marrow Transplantation Social Bookmarking                   What's this?

Autologous Bone Marrow Transplantation and Hyperbaric Oxygen Therapy for Patients With Thromboangiitis Obliterans

Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan, shigerus{at}showa.gunma-u.ac.jp

Koichi Nishikawa, MD

Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan

Hideaki Obata, MD

Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan

Fumio Goto, MD

Department of Anesthesiology, Gunma University Graduate School of Medicine, Maebashi, Japan

Many patients suffering from severe ischemic limb disease inevitably experience amputation, despite intensive therapies. Sympathectomy and hyperbaric oxygen therapy are optional therapies for patients with peripheral circulation disorders. Recently, several clinical studies have established that implantation of bone marrow—mononuclear cells into ischemic limbs increases collateral vessel formation. In the present study, autologous implantation of bone marrow—mononuclear cells was prescribed to 7 patients with ischemic limbs because of peripheral arterial disease. Although the extent of the improvement was not consistent among the 7 cases, all of the patients experienced some improvement in their symptoms. Transcutaneous oxygen partial pressure measured in a hyperbaric chamber increased in 5 patients. No side effects were observed. In conclusion, combined use of autologous bone marrow transplantation and hyperbaric oxygen therapy may be safe and effective for achievement of therapeutic angiogenesis.

This version was published on September 1, 2007

Angiology, Vol. 58, No. 4, 429-434 (2007)
DOI: 10.1177/0003319706292015


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?